Drug Class
complement C5 inhibitor
Type
ingredient
Active Ingredient
ravulizumab
📋Overview
Ravulizumab is a monoclonal antibody designed to inhibit a part of the immune system known as the complement system. It is primarily associated with rare blood disorders that involve abnormal destruction of red blood cells, such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). By targeting specific proteins in the complement pathway, ravulizumab helps reduce the underlying immune activity that contributes to these conditions. Its use reflects advances in targeted therapies for complex immune-mediated diseases.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for ravulizumab
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.